TREM2 and metabolic dysfunction-associated steatotic liver disease: Hepatic gene expression of TREM2 correlated with all the investigated features of NAFLD, overall suggesting that also in humans, TREM2 might be implicated in the development of NAFLD and its progression into NASH.